Jon Saxe, Director at Sciclone Pharmaceuticals, holds 55.75K shares in VistaGen Therapeutics (Ticker: VTGN), holds 177.81K shares in Durect (Ticker: DRRX), holds 105.00K shares in Sciclone Pharmaceuticals (Ticker: SCLN). Most recently, Jon Saxe Bought ― shares of VistaGen Therapeutics on Mar 22, 2021 for an estimated value of 3.75K.